Pityriasis Rosea is a common, self-limiting rash that affects people of all ages. It is characterized by a single, large scaly patch or “herald patch” that is usually red or pink in color. This is followed by multiple smaller patches that are usually oval or round in shape. The rash typically appears on the chest, back, arms, and legs and can last anywhere from a few weeks to a few months. While the rash is usually not itchy or painful, it can be uncomfortable and cause embarrassment.
The exact cause of Pityriasis Rosea is unknown, but it is believed to be caused by a virus. It is not contagious, and it is not caused by contact with an infected person. It is also not caused by poor hygiene or any other environmental factor.
Pityriasis Rosea is usually diagnosed based on the appearance of the rash. A doctor may also take a skin sample to confirm the diagnosis. In some cases, a blood test may be necessary to rule out other conditions that can cause a similar rash.
Most cases of Pityriasis Rosea do not require medical treatment, as the rash usually resolves on its own within a few weeks or months. However, some people may experience itching or discomfort, and in these cases, treatment may be necessary. Treatment options include topical corticosteroids, oral antihistamines, and ultraviolet light therapy.
Since the exact cause of Pityriasis Rosea is unknown, there is no known way to prevent the condition. However, there are some steps that can be taken to reduce the risk of developing the condition. These include avoiding stress, maintaining good hygiene, and avoiding contact with people who have the condition.
Pityriasis Rosea is a common, self-limiting skin condition that typically resolves on its own over a few weeks or months. While there is no known way to prevent the condition, there are steps that can be taken to reduce the risk of developing it. Treatment is usually not necessary, but in cases where itching or discomfort is present, topical corticosteroids, oral antihistamines, and ultraviolet light therapy may be used.
1.
Radionuclide-Containing Combo Slows Metastatic Prostate Cancer, Improves Survival
2.
a cutting-edge cancer diagnostic tool.
3.
DBT Reduced Suicide Attempts in Adolescents with Bipolar Disorder.
4.
To automate the biopharmaceutical facilities of Reliance Life Sciences, ABB India has won the contract.
5.
In cases of locally advanced, potentially curable pancreatic cancer, a combination of drugs enhances the results of radiation therapy.
1.
Multidisciplinary Insights into Diagnosis, Management, and Outcomes in Oncology
2.
The Role of Alanine Aminotransferase in Liver Health and Disease
3.
Interpreting Iron Studies: What Your Blood Results Really Mean
4.
Deep Learning Fluorescence Imaging for Oral Cancer Surgery: In Silico Depth Quantification
5.
Lentigo Maligna Melanoma: Everything You Need To Know about This Skin Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
2.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion IV
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
4.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
5.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation